Radiolabeled Monoclonal Antibody in Treating Patients With Progressive Metastatic Androgen-Independent Adenocarcinoma (Cancer) of the Prostate

NCT00081172 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

RADIATION: lutetium Lu 177 monoclonal antibody J591

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]